Our data provides new insights to the development of novel strategies to inhibit tumor angiogenesis in glioma by targeting Bmi-1, suggesting a necessity of further investigations of the anti-glioma therapeutic value of Bmi-1. The gene discussed is BMI1; the disease is glioma.